The 2nd Annual CPLM Summit

Fencing off the increased competition from biosimilars and generics, combination products and value-added features are now seen as a differentiated route to pharma/ drug developers as a lifecycle maximization strategy.

Over the last 2 years, more emphasis is placed on understanding market trends and establishing a robust framework of lifecycle management (LCM) amongst industry leaders, especially from a design control and risk mitigation perspective.

At the same time, the surge of digital platforms and connected technology presents lucrative opportunities to combo products developers – not only from a commercial perspective but also patient adherence, which will subsequently aids competitive advantage.

So what’s the best approach to managing your LCM? How to tailor your program and ensure it’s fit-for-purpose and cost-efficient?

This 3-day summit will focus on LCM of combination devices, equipping the community with a holistic view of the following areas through operational case studies:

  • LCM strategies tailored for combination products
  • Quality risk management for ageing combo products
  • Design control and testing techniques during combination product upgrade

Join us in Boston to be part of the community!